OTC skin protectants
This article was originally published in The Rose Sheet
Executive Summary
FDA denies Cosmetic, Toiletry and Fragrance Association request to stay enforcement action on OTC skin protectant final monograph in a Feb. 24 letter to the association. Request to stay action is "moot" after FDA granted CTFA's citizen petition request to include the indications "help prevent" and "chafing" in monograph in a technical amendment published Dec. 9 in the Federal Register (1"The Rose Sheet" Dec. 15, 2003, p. 10). Compliance dates for OTC skin protectant drug products are June 6, 2005 for products with annual sales less than $25,000 and June 4, 2004 for all others. FDA released the rule June 4 (2"The Rose Sheet" June 9, 2003, p. 3)...
You may also be interested in...
Skin Protectant Rule Amended To Include Prevention, Chafing Indications
FDA will permit optional labeling language for OTC skin protectant drug products to include the indications "helps prevent" and "chafed" under a technical amendment to the final monograph, published in the Federal Register Dec. 9
Biotherm Biovitamin Marks Brand Foray Into Teen Skin Care Segment
Biotherm will enter the teen skin care market in August with Biovitamin cleanser and moisturizer targeted to young women ages 15-21 with normal to combination skin, the L'Oréal division said
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.